BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28713902)

  • 21. A bioinformatics transcriptome meta-analysis highlights the importance of trophoblast differentiation in the pathology of hydatidiform moles.
    Desterke C; Slim R; Candelier JJ
    Placenta; 2018 May; 65():29-36. PubMed ID: 29908639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrent complete hydatidiform mole: where we are, is there a safe gestational horizon? Opinion and mini-review.
    Kalogiannidis I; Kalinderi K; Kalinderis M; Miliaras D; Tarlatzis B; Athanasiadis A
    J Assist Reprod Genet; 2018 Jun; 35(6):967-973. PubMed ID: 29737470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of maspin in gestational trophoblastic disease.
    Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF
    Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Partial hydatidiform mole: a common but underdiagnosed condition. A 3-year retrospective clinicopathological and DNA flow cytometric analysis.
    Jeffers MD; O'Dwyer P; Curran B; Leader M; Gillan JE
    Int J Gynecol Pathol; 1993 Oct; 12(4):315-23. PubMed ID: 8253548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of nonsynonymous TP53 mutations in hydatidiform moles.
    Chan KK; Wong ES; Wong OG; Ngan HY; Cheung AN
    Mutat Res; 2018 May; 809():20-23. PubMed ID: 29655027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic studies in hydatidiform mole with clinical correlations.
    Lawler SD; Fisher RA
    Placenta; 1987; 8(1):77-88. PubMed ID: 3473466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histopathological and immunohistochemical features of early hydatidiform mole in relation to subsequent development of persistent gestational trophoblastic disease.
    Petts G; Fisher RA; Short D; Lindsay I; Seckl MJ; Sebire NJ
    J Reprod Med; 2014; 59(5-6):213-20. PubMed ID: 24937960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expression of TM4SF9 in human trophoblasts].
    Gao TY; Yu YH
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):1080-2. PubMed ID: 18583270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydatidiform mole diagnostics using circulating gestational trophoblasts isolated from maternal blood.
    Sunde L; Singh R; Ravn K; Schelde P; Hansen ES; Uldbjerg N; Niemann I; Hatt L
    Mol Genet Genomic Med; 2021 Jan; 9(1):e1565. PubMed ID: 33306861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression of p57 marker in differential diagnosis of complete and partial mole - correlation with DNA analysis].
    Cierna Z; Palkovič M; Danihel Ml L; Danihel L; Repiská V; Vojtaššák J; Korbeľ M
    Cesk Patol; 2012 Oct; 48(4):218-21. PubMed ID: 23121032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [MMP-2/TIMP-2 expression in the trophoblasts of patients with gestational trophoblastic disease].
    Ding F; Zhang QS; Xing FQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Feb; 27(2):150-2. PubMed ID: 17355922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular and histological characteristics of early triploid and partial molar pregnancies.
    Kubelka-Sabit K; Jasar D; Filipovski V; Bozinovski G; Plaseska-Karanfilska D
    Pol J Pathol; 2017; 68(2):138-143. PubMed ID: 29025247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Invasive Complete Hydatidiform Moles: Analysis of a Case Series With Genotyping.
    Bynum J; Murphy KM; DeScipio C; Beierl K; Adams E; Anderson D; Vang R; Ronnett BM
    Int J Gynecol Pathol; 2016 Mar; 35(2):134-41. PubMed ID: 26535984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of Neoplastic Transformation of Hydatidiform Mole: Current Evidence.
    Laban M; El-Swaify ST; Refaat MA; Ibrahim EA; Abdelrahman RM
    Reprod Sci; 2021 Oct; 28(10):3010-3012. PubMed ID: 34341951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diploid hydatidiform moles with fetal red blood cells in molar villi. 2--Genetics.
    Fisher RA; Paradinas FJ; Soteriou BA; Foskett M; Newlands ES
    J Pathol; 1997 Feb; 181(2):189-95. PubMed ID: 9120724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic mechanisms regulate placental c-myc and hTERT in normal and pathological pregnancies; c-myc as a novel fetal DNA epigenetic marker for pre-eclampsia.
    Rahat B; Hamid A; Ahmad Najar R; Bagga R; Kaur J
    Mol Hum Reprod; 2014 Oct; 20(10):1026-40. PubMed ID: 25024139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The tumor suppressor gastrokine-1 is expressed in placenta and contributes to the regulation of trophoblast migration.
    Fahlbusch FB; Ruebner M; Huebner H; Volkert G; Zuern C; Thiel F; Koch M; Menendez-Castro C; Wachter DL; Hartner A; Rascher W
    Placenta; 2013 Nov; 34(11):1027-35. PubMed ID: 23993393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Genetic advances in hydatidiform mole].
    Wang J; Wu SY; Zhang XW
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):548-50. PubMed ID: 17068633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential distribution of placental leucine aminopeptidase/oxytocinase and aminopeptidase A in human trophoblasts of normal placenta and complete hydatidiform mole.
    Nomura M; Tsukahara S; Ando H; Katsumata Y; Okada M; Itakura A; Nomura S; Kikkawa F; Nagasaka T; Mizutani S
    Placenta; 2002; 23(8-9):631-9. PubMed ID: 12361682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Mismatch repair gene promoter methylation and expression in hydatidiform moles and the malignant transformation].
    Zhu CK; Ye DF; Xie X; Cheng XD; Chen HZ; Lu WG
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):422-6. PubMed ID: 12974087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.